Over-the-counter histamine2-blocker therapy.
In determining whether a prescription medication should be granted OTC status, the risks and benefits of treatment with the medication must be weighed. Ultimately, the decision must be made with some degree of uncertainty. Pharmacists must take advantage of this uncertainty to demonstrate their professional expertise and value to society. The Rx-to-OTC switch for H2-blockers may benefit many, although not all, patients with acid peptic complaints, and it offers pharmacists an opportunity to demonstrate their willingness and ability to assist in the use of cost-effective OTC drug therapy.[1]References
- Over-the-counter histamine2-blocker therapy. Gonzalez, E.R., Grillo, J.A. The Annals of pharmacotherapy. (1994) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
